These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31631559)

  • 1. Bruceine D inhibits tumor growth and stem cell-like traits of osteosarcoma through inhibition of STAT3 signaling pathway.
    Wang S; Hu H; Zhong B; Shi D; Qing X; Cheng C; Deng X; Zhang Z; Shao Z
    Cancer Med; 2019 Dec; 8(17):7345-7358. PubMed ID: 31631559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bruceantinol targeting STAT3 exerts promising antitumor effects in in vitro and in vivo osteosarcoma models.
    Miao J; Chen S; Cao H; Ding Z; Li Y; Wang W; Nundlall K; Deng Y; Li J
    Mol Carcinog; 2024 Jun; 63(6):1133-1145. PubMed ID: 38426797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dioscin inhibits stem-cell-like properties and tumor growth of osteosarcoma through Akt/GSK3/β-catenin signaling pathway.
    Liu W; Zhao Z; Wang Y; Li W; Su Q; Jia Q; Zhang J; Zhang X; Shen J; Yin J
    Cell Death Dis; 2018 Mar; 9(3):343. PubMed ID: 29497056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin Suppresses Self-Renewal Ability and Tumorigenicity of Osteosarcoma Stem Cells via Reactive Oxygen Species-Mediated Apoptosis and Autophagy.
    Zhao B; Luo J; Wang Y; Zhou L; Che J; Wang F; Peng S; Zhang G; Shang P
    Oxid Med Cell Longev; 2019; 2019():9290728. PubMed ID: 31827709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3.
    Tu B; Zhu J; Liu S; Wang L; Fan Q; Hao Y; Fan C; Tang TT
    Oncotarget; 2016 Jul; 7(30):48296-48308. PubMed ID: 27340780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Methoxydalbergione suppresses growth and induces apoptosis in human osteosarcoma cells in vitro and in vivo xenograft model through down-regulation of the JAK2/STAT3 pathway.
    Park KR; Yun HM; Quang TH; Oh H; Lee DS; Auh QS; Kim EC
    Oncotarget; 2016 Feb; 7(6):6960-71. PubMed ID: 26755649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynasore suppresses cell proliferation, migration, and invasion and enhances the antitumor capacity of cisplatin via STAT3 pathway in osteosarcoma.
    Zhong B; Shi D; Wu F; Wang S; Hu H; Cheng C; Qing X; Huang X; Luo X; Zhang Z; Shao Z
    Cell Death Dis; 2019 Sep; 10(10):687. PubMed ID: 31534119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
    Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
    Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glaucocalyxin A-induced oxidative stress inhibits the activation of STAT3 signaling pathway and suppresses osteosarcoma progression in vitro and in vivo.
    Mao M; Zhang T; Wang Z; Wang H; Xu J; Yin F; Wang G; Sun M; Wang Z; Hua Y; Cai Z
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1214-1225. PubMed ID: 30659925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol eliminates cancer stem cells of osteosarcoma by STAT3 pathway inhibition.
    Peng L; Jiang D
    PLoS One; 2018; 13(10):e0205918. PubMed ID: 30356255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Water extract of sporoderm-broken spores of Ganoderma lucidum enhanced pd-l1 antibody efficiency through downregulation and relieved complications of pd-l1 monoclonal antibody.
    He J; Zhang W; Di T; Meng J; Qi Y; Li G; Zhang Y; Su H; Yan W
    Biomed Pharmacother; 2020 Nov; 131():110541. PubMed ID: 33152901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-walled carbon nanotube: One specific inhibitor of cancer stem cells in osteosarcoma upon downregulation of the TGFβ1 signaling.
    Miao Y; Zhang H; Pan Y; Ren J; Ye M; Xia F; Huang R; Lin Z; Jiang S; Zhang Y; Songyang Z; Zhang Y
    Biomaterials; 2017 Dec; 149():29-40. PubMed ID: 28988062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bruceine A induces cell growth inhibition and apoptosis through PFKFB4/GSK3β signaling in pancreatic cancer.
    Zhang P; Tao W; Lu C; Fan L; Jiang Q; Yang C; Shang E; Cheng H; Che C; Duan J; Zhao M
    Pharmacol Res; 2021 Jul; 169():105658. PubMed ID: 33992797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chloroquine suppresses proliferation and invasion and induces apoptosis of osteosarcoma cells associated with inhibition of phosphorylation of STAT3.
    Chen C; Zhang H; Yu Y; Huang Q; Wang W; Niu J; Lou J; Ren T; Huang Y; Guo W
    Aging (Albany NY); 2021 Jun; 13(13):17901-17913. PubMed ID: 34170850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KLF4 functions as an oncogene in promoting cancer stem cell-like characteristics in osteosarcoma cells.
    Qi XT; Li YL; Zhang YQ; Xu T; Lu B; Fang L; Gao JQ; Yu LS; Zhu DF; Yang B; He QJ; Ying MD
    Acta Pharmacol Sin; 2019 Apr; 40(4):546-555. PubMed ID: 29930276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the JAK2/STAT3 signaling pathway exerts a therapeutic effect on osteosarcoma.
    Yan J; Wang Q; Zou K; Wang L; Schwartz EB; Fuchs JR; Zheng Z; Wu J
    Mol Med Rep; 2015 Jul; 12(1):498-502. PubMed ID: 25760445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cinobufagin Suppresses The Characteristics Of Osteosarcoma Cancer Cells By Inhibiting The IL-6-OPN-STAT3 Pathway.
    Zhang C; Ma K; Li WY
    Drug Des Devel Ther; 2019; 13():4075-4090. PubMed ID: 31824138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium cantharidate targets STAT3 and abrogates EGFR inhibitor resistance in osteosarcoma.
    Ji XL; He M
    Aging (Albany NY); 2019 Aug; 11(15):5848-5863. PubMed ID: 31422383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma.
    Oi T; Asanuma K; Matsumine A; Matsubara T; Nakamura T; Iino T; Asanuma Y; Goto M; Okuno K; Kakimoto T; Yada Y; Sudo A
    Int J Oncol; 2016 Dec; 49(6):2275-2284. PubMed ID: 27840900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of the metabolic modulator Metformin on osteosarcoma cancer stem-like cells.
    Paiva-Oliveira DI; Martins-Neves SR; Abrunhosa AJ; Fontes-Ribeiro C; Gomes CMF
    Cancer Chemother Pharmacol; 2018 Jan; 81(1):49-63. PubMed ID: 29086064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.